Optimal Time-to-Market for Life-Saving Biopharmaceuticals

Rentschler Biopharma offers bioprocess development and cGMP manufacturing for high-quality biopharmaceuticals. The company’s strength lies in its extensive experience with complex proteins and exceptional track record of over 100 different therapeutic protein formats.

Rentschler provides the best solution to guarantee the success of its client’s project and meet clinical and commercial needs.

The company leverages its established know-how to evaluate the best production approach for its client’s molecule and offers tailor-made timelines for therapeutics. By accelerating timelines via economically attractive process options, it generates competitive advantages for its client’s product, without compromising quality or safety.

Rentschler’s best-in-class project management team ensures that needs are reflected in every detail of project design, planning and execution from the beginning. It couples this collaborative approach with its deep knowledge of regulatory affairs. This results in an unrivalled track record in successful audits and approvals from health authorities around the globe.

Rentschler’s website offers additional information about the company’s accelerated timelines, considering economically attractive process options.


Rentschler Biopharma SE

Erwin-Rentschler-Str. 21
88471 Laupheim

+49 7392 701-0
+49 7392 701-300